http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020000163-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a521cfa321c963978df8ae98a84056a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
filingDate 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2543392b31fbefd0d1efe9f138f5779
publicationDate 2020-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2020000163-A
titleOfInvention Fatty oil-containing calcium β-hydroxy-β-methylbutyrate powder, tablet
abstract An object of the present invention is to provide an HMB-Ca capable of suppressing tableting trouble during tableting while suppressing bitterness of the HMB-Ca. Another object of the present invention is to provide a tablet containing HMB-Ca and having good disintegration properties. In order to solve the above-mentioned problems, an oil-and-fat-containing calcium β-hydroxy-β-methylbutyrate powder comprising a powdery fat and oil and a powdery calcium β-hydroxy-β-methylbutyrate, wherein The powdered fat contains a fat (A) having a melting point of 40 to 70 ° C. and a solid fat content of 20 to 100% at 35 ° C., an emulsifier (B), and an excipient (C). The content of the fat or oil (A) is 40 to 75% by mass, the content of the emulsifier (B) in the powder or fat is 2.5 to 13% by mass, and the excipient ( Provided is an oil / fat-containing calcium β-hydroxy-β-methylbutyrate powder having a content of C) of 22% by mass or more. [Selection diagram] None
priorityDate 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453877327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3527278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453668266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260545
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447653863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24892726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407568324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9860341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74083232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133893

Total number of triples: 32.